|
Volumn 13, Issue 1, 2007, Pages 6-7
|
The prevention and treatment of restenosis in the era of drug-eluting stent
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLIMIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BAICALIN;
CALCIUM CHANNEL BLOCKING AGENT;
CHINESE DRUG;
EMODIN;
GLITAZONE DERIVATIVE;
HIRUDIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TETRAMETHYLPYRAZINE;
TONGGUAN;
UNCLASSIFIED DRUG;
XIONGSHAO;
CHINESE MEDICINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ELUTING STENT;
DRUG MECHANISM;
EVIDENCE BASED MEDICINE;
HISTORY OF MEDICINE;
HUMAN;
PATHOGENESIS;
PERCUTANEOUS CORONARY INTERVENTION;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
SHORT SURVEY;
THROMBOSIS;
VASCULAR ENDOTHELIUM;
CORONARY RESTENOSIS;
CORONARY STENOSIS;
DRUG DELIVERY SYSTEMS;
HUMANS;
MEDICINE, CHINESE TRADITIONAL;
STENTS;
|
EID: 34047256818
PISSN: 16720415
EISSN: None
Source Type: Journal
DOI: 10.1007/s11655-007-0006-z Document Type: Short Survey |
Times cited : (1)
|
References (5)
|